Innovative Tissue Models MatTek's leadership in developing advanced 3D reconstructed human tissue models, including skin, ocular, and respiratory tissues, presents a compelling opportunity for organizations seeking more reliable, human-relevant testing alternatives across Cosmetics, Chemicals, and Pharmaceuticals.

Global Production Footprint With facilities in the US, Europe, and China, MatTek offers a geographically diverse supply chain and technical support, enabling potential customers worldwide to adopt its innovative models with reduced logistical barriers and enhanced local service.

Recent Product Launches The launch of the groundbreaking EpiLiver tissue model and advanced spheroid cultureware signals ongoing innovation, opening avenues for sales in niche areas such as hepatotoxicity testing and complex cell culture applications for drug development and safety assessment.

Strategic Collaborations Partnerships with industry leaders like Charles River Laboratories and attendance at key scientific events enhance market visibility and foster potential co-development opportunities, making it easier to position new or expanded product offerings to targeted research institutions.

Financial Growth Potential With revenues estimated between $10M and $25M, and recent investments and acquisitions, MatTek appears poised for growth, indicating a promising target for sales of complementary laboratory technologies, cultureware, and contract research services within the biotech and regulatory sectors.